Braveheart Bio, Inc. (NASDAQ:BRVE – Get Free Report) insider Michele Anderson purchased 1,111 shares of Braveheart Bio stock in a transaction dated Friday, August 7th. Braveheart Bio Stock Up 0.7%Shares of BRVE stock opened at $30.00 on Friday. Braveheart Bio, Inc. has a 1-year low of $28.47 and a 1-year high of $32.00. Get Braveheart Bio alerts:About Braveheart Bio(Get Free Report)Recommended StoriesWe are a clinical‑stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (“HCM”) and other serious cardiovascular diseases. Receive News & Ratings for Braveheart Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braveheart Bio and related companies with MarketBeat.com's FREE daily email newsletter.